Market Insights & Analysis from Kramer Capital Research

Market Insights & Analysis from Kramer Capital Research

Don’t Short These Netflix Numbers, But Don’t Dump Disney Either

April 19, 2019

Netflix Inc. (NASDAQ:NFLX) dived 9 percent minutes after its 1Q19 earnings report hit Wall Street and a lot of people who should know better explained the move by claiming that guidance had fallen off a cliff. After all, audience expansion had slowed, content spending had accelerated and once-friendly partnerships with studios like The Walt Disney […]

Avoid Lyft and Uber IPOs and Consider Buying Four True Biotech Unicorns

April 12, 2019

Lyft Inc. (NASDAQ:LYFT) has been a serious disappointment to investors who had hoped that a stock which went public at $72 a share would instantly prove that it was worth a lot more than that. Warren Buffett himself has called the ride-sharing company a waste of its $25 billion market capitalization. Carl Icahn dumped a […]

Tech Trumps Growth in This Market

April 5, 2019

Last week, I discussed the “Sweet 16” stocks that had appeared on my screen. These are the stocks that are growing at a healthy speed despite what looks like a sluggish season for the overall corporate financial outlook. Think of it as my off-Nasdaq bracket of dynamic Wall Street names with hustle. To use a […]

Subscribe to GameChangers

Hilary Kramer’s flagship newsletter, GameChangers identifies breakthrough, mega-trendsetter stocks ahead of the Wall Street herd, with a goal of delivering at least one double-digit gain every month. Click here now to learn more about GameChangers.

Subscribe to Value Authority

Value Authority targets undervalued stocks with strong fundamentals: cash, earnings and valuation. These plays are especially effective because they offer a strong margin of safety to sustain any macro issues, such as higher rates or a slowing economy, while providing consistent double-digit returns in any market. Value Authority guarantees at least 10 double-digit wins per year. Click here now to learn more about Value Authority.

Subscribe to High Octane Trader

Since High Octane Trader’s launch in 2011, readers have had the opportunity to bank over 600 winning options trades, and score wins at an 80% success rate over the last 12 months. High Octane Trader members expect quick-hitting gains and outsized payoffs, while trading several times per week. Click here now to learn more about High Octane Trader.

Subscribe to Turbo Trader

The Turbo Trader portfolio focuses on bargain-priced ETFs, stocks, and commodities that are technically and fundamentally positioned to skyrocket over the coming one to three months. Click here now to learn more about Turbo Trader.

Subscribe to Inner Circle

Membership in the Inner Circle features access to all four Hilary Kramer services:  GameChangers, Value Authority, High Octane Trader, and Turbo Trader.  As an Inner Circle member, you’ll also have access to exclusive stock picks, videos, live online chats, direct access to Hilary, and more. Click here now to learn more about Inner Circle.

Big Stock Wins

Stock NameDays HeldProfit
Sirius XM Radio344136.6%
Medical Action Industries51107.9%
Dot Hill Systems777.80%

Big Option Wins

Stock NameDays HeldProfit
Tempur Sealy International19243.4%
Ebay8157.8%
Google2154.3%
Regeneron Pharmaceuticals7131.4%

Testimonials

Investing has become fun, because most of your recommendations are winners.

— Gerhild T.

After 10 trades I am averaging 30%+!

— Bob

It is the best publication I have ever seen.  And I have seen probably 100 in my investment career which spans 56 years.

— Martin G.
Exclusive Report: 3 Biotech Breakthroughs To Bank On
X
Hilary Kramer
Legendary Wall St. trader Hilary Kramer

Where does the Smart Money look for the best biotech stocks? Small- and mid-cap biotechs. They're the ones with the ability to transform the world, and bring investors transformational profits. To get free access to Hilary Kramer's latest report, 3 Biotech Breakthroughs To Bank On, simply tell us where to send it in the box below.

Along with my FREE report, Hilary Kramer's 3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk.
* We value your privacy. You will not be spammed, ever. Period.

Log In

Forgot Password

Search